These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4338965)

  • 21. [Immunogenic and antigenic properties of soluble pertussis antigens].
    Moskalenko EP
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Sep; 46(9):42-6. PubMed ID: 4311503
    [No Abstract]   [Full Text] [Related]  

  • 22. Suppression of SV40 tumors after immunization with group A Streptococcus pyogenes and Bordetella pertussis.
    Collins JL; Wust CJ
    Cancer Res; 1974 May; 34(5):932-7. PubMed ID: 4363064
    [No Abstract]   [Full Text] [Related]  

  • 23. Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation.
    Allison AC; Davies AJ
    Nature; 1971 Oct; 233(5318):330-2. PubMed ID: 4940426
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of Bordetella pertussis on the lymphatic tissue of mice. 8. The influence of Bordetella pertussis on the primary and secondary immune potential of thymusless ("nude") mice (author's transl)].
    Finger H; Mohr W; Hof H; Elekes E; Plager L
    Med Microbiol Immunol; 1973 Sep; 159(1):13-38. PubMed ID: 4358740
    [No Abstract]   [Full Text] [Related]  

  • 25. [The presence of a substance complementary to the agglutinogen of B. pertussis in the serum of normal mice].
    Kuznetsov EA
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):81-4. PubMed ID: 4337416
    [No Abstract]   [Full Text] [Related]  

  • 26. Mode of action of adjuvants: retinol and other lysosome-labilizing agents as adjuvants.
    Spitznagel JK; Allison AC
    J Immunol; 1970 Jan; 104(1):119-27. PubMed ID: 4903997
    [No Abstract]   [Full Text] [Related]  

  • 27. Bordetella pertussis iron regulated proteins as potential vaccine components.
    Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
    Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Removal of lipopolysaccharide from acellular Bordetella pertussis vaccine by detergent treatment.
    Stinson RS; Lemmon RD; Baggett DW; Huff TL; Malone JA; Sloan GL; Winters AL
    J Biol Stand; 1986 Oct; 14(4):261-71. PubMed ID: 2881930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adjuvant role of the lipopolysaccharide from Bordetella pertussis in the induction of experimental allergic encephalomyelitis. Induction of a subacute form in the rabbit and inhibition of this adjuvant effect].
    Moulias R; Peetoom F
    Pathol Biol; 1968 Oct; 16(19):853-8. PubMed ID: 4302102
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental relation between leukocytosis and other factors of Bordetella pertussis].
    Ruiz Puente J; Rivera Rivera D; González Pacheco M
    Salud Publica Mex; 1981; 23(6):613-20. PubMed ID: 6278659
    [No Abstract]   [Full Text] [Related]  

  • 31. [Influence of Bordetella pertussis on the lymphatic tissue of mice. VII. Studies on the relationships between the various biological effects induced by Bordetella pertussis].
    Finger H; Stein P; Beneke G; Emmerling P; Plager L
    Med Microbiol Immunol; 1972; 157(4):265-90. PubMed ID: 4343422
    [No Abstract]   [Full Text] [Related]  

  • 32. Loss of protective antigen, histamine-sensitising factor and envelope polypeptides in cultural variants of Bordetella pertussis.
    Wardlaw AC; Parton R; Hooker MJ
    J Med Microbiol; 1976 Feb; 9(1):89-100. PubMed ID: 57240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple chemically defined medium for the production of phase I Bordetella pertussis.
    Stainer DW; Scholte MJ
    J Gen Microbiol; 1970 Oct; 63(2):211-20. PubMed ID: 4324651
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of the indices of humoral and cellular immunity induced in mice of various genotypes by pertussis antigens].
    Moskalenko EP; Il'ina SI; Plavan VV
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):89-92. PubMed ID: 6318483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Characteristics of a soluble antigen of Haemophilus pertussis obtained by sucrose extraction].
    Nikolaev AI; Oster NR; Korovkina GV
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Feb; 45(2):8-13. PubMed ID: 4297129
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunological and histological reactions to respiratory administration of ribosomal Bordetella pertussis vaccine in mice.
    Bartlema HC; Braunius R
    Z Erkr Atmungsorgane; 1979 May; 153(2):254-60. PubMed ID: 232799
    [No Abstract]   [Full Text] [Related]  

  • 37. Action of vaccinia virus on the reactivity of albino mice inoculated with pertussis vaccine.
    Pozsgi N; David C; Andreescu V; Caffé I; Ghyka G
    Z Immunitatsforsch Exp Klin Immunol; 1971 Aug; 142(2):129-35. PubMed ID: 4105636
    [No Abstract]   [Full Text] [Related]  

  • 38. Adjuvant activity of Bordetella pertussis in New Zealand mice.
    Finger H; Hof H; Elekes E; Plager L
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 147(5):437-40. PubMed ID: 4377488
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of adjuvants and stress on the production of IgE antibody in rats.
    Meacock SC; Marsden CH
    Int Arch Allergy Appl Immunol; 1973; 45(1):136-7. PubMed ID: 4353765
    [No Abstract]   [Full Text] [Related]  

  • 40. Variation in Bordetella pertussis.
    Cameron J
    J Pathol Bacteriol; 1967 Oct; 94(2):367-74. PubMed ID: 4294462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.